Vaccine

Details for Australian Patent Application No. 2009217425 (hide)

Owner GlaxoSmithKline Biologicals S.A. Utrecht University

Inventors Poolman, Jan; Tommassen, Johannes Petrus Maria; Bos, Martine Petronello; Stork, Michiel; Weynants, Vincent

Agent Shelston IP

Pub. Number AU-A-2009217425

Priority 0816447.7 08.09.08 GB

Filing date 6 March 2009

Wipo publication date 25 March 2010

International Classifications

C07K 14/22 (2006.01) Peptides having more than 20 amino acids

Event Publications

25 March 2010 Application Open to Public Inspection

  Published as AU-A-2009217425

25 March 2010 PCT application entered the National Phase

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009217426-A mine dewatering apparatus and coupling therefor

2009217424-Switch board smoke detector monitoring system